Protalix BioTherapeutics, Inc. of HACKENSACK, NJ filed a DEF 14A with the SEC on 2023-05-18. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | DEF 14A | DEF 14A |
| 2 | GRAPHIC | GRAPHIC |
| 3 | GRAPHIC | GRAPHIC |
| 4 | GRAPHIC | GRAPHIC |
| 5 | GRAPHIC | GRAPHIC |
Showing 12 of 57 filings.
| Filed | Form |
|---|---|
| 2026-04-30 | DEF 14A |
| 2025-04-30 | DEF 14A |
| 2024-05-17 | DEFA14A |
| 2024-04-29 | DEF 14A |
| 2023-06-28 | DEFA14A |
| 2023-05-18 | DEF 14A |
| 2023-05-02 | PRE 14A |
| 2022-06-16 | DEFA14A |
| 2022-04-29 | DEF 14A |
| 2022-04-14 | PRE 14A |
| 2021-11-09 | DEFA14A |
| 2021-09-30 | DEF 14A |